Selling a veterinary practice is a structured process, not a single transaction: you prepare the practice's records, entity and licenses, run a process that lets more than one buyer type compete — your associate, an independent veterinarian, a regional group or corporate consolidator, or a private-equity-backed platform — then negotiate the structure, your own non-compete and work-back terms, and what happens to the team you leave behind.
This guide walks through each stage.
Rules vary by state and change
This guide explains federal rules and the state rules it names, as of the date above.
Employment law and veterinary practice rules differ by state and are revised often, so confirm current requirements with your state veterinary board, labor agency or employment counsel before you act on them.
It is general information, not legal advice.
When should you start preparing to sell?
Preparation is the only part of a sale you fully control.
Start by deciding what the sale is for: the highest clean price, keeping the practice in known hands, or stepping back gradually.
If it is the third, internal succession planning is a different path from a sale.
Assemble the file a buyer will underwrite.
AVMA's 2024 Veterinary Practice Owners Survey sketches the asset: half of surveyed practices (50.6%) had been in business at least 21 years, and 56.6% were 100% brick-and-mortar.
Expect to show several years of financial statements and tax returns, payroll records, fee schedules and an equipment list.
Entity and real-estate structure decides what is actually for sale.
In AVMA's 2024 survey, 54.9% of owners held the practice in one legal entity and the land and buildings in a separate entity — so whether the building is part of your deal is its own negotiation.
Walk the regulatory perimeter early, because the registrations that let a practice operate do not automatically move with the keys.
A DEA registration cannot be assigned or transferred except on conditions the DEA specifically designates and then only with its written consent — a buyer cannot simply take over yours.
Premises permits are state law: a California premises registration cannot be transferred at all, and on a change of owner or operator the registration holder must notify the board within 30 days after the change, with the buyer filing a new registration.
Put the controlled-substance and premises-permit handoffs into the deal timeline, not the week of closing.
Who buys veterinary practices?
Four buyer types are the ones to weigh, and they are not interchangeable:
- An associate or partner buying in. The buyer who already knows your clients and your standards. The trade-off is a thin market: one buyer means one negotiation, so build competition into the process even when you don't have it.
- An independent veterinarian buying their first practice. What happens after closing reflects one person's plans rather than a platform's playbook.
- A regional group or corporate consolidator. A company that owns multiple practices and folds yours into its systems. The FTC's Ethos complaint described a growing trend of consolidation by large chains in U.S. emergency and specialty veterinary markets.
- A private-equity-backed platform. An investor-backed acquirer building a portfolio. The FTC's Bureau of Competition director said in 2022 that private equity firms increasingly use roll-up strategies that build market power off the FTC's radar.
A public window into the larger deals is the FTC's enforcement record.
In 2017 the agency required Mars to divest 12 specialty and emergency clinics as a condition of its $9.1 billion acquisition of VCA Inc. In June 2022 it required JAB Consumer Partners to divest clinics in California and Texas as a condition of its $1.1 billion acquisition of SAGE Veterinary Partners, and to get FTC prior approval before buying specialty or emergency clinics within 25 miles of its clinics in those states.
Two messages for a seller there.
Platform buyers are active, financed acquirers — but if your specialty or emergency hospital sits near the buyer's existing clinics, antitrust conditions can shape what that buyer may purchase and when.
And the buyer types value different things, so talk to more than one of them before judging any offer.
Which deal structures and seller terms should you negotiate?
The headline price is the least of it.
What you negotiate is the structure: what is sold, what is paid at closing versus later, what you do after closing, and how the price is allocated.
Start with what is being sold: the practice's assets, or the ownership entity itself.
It decides what transfers and what stays with you, and it drives the tax questions each side takes to their adviser.
Where goodwill could attach in an asset purchase, generally both the purchaser and the seller must file IRS Form 8594 with their income tax returns to report how the price is allocated.
Under the form's classes, goodwill and going concern value are Class VII assets, and a covenant not to compete entered into in connection with buying the business is a Class VI (section 197) intangible.
The allocation is a negotiation, not a formality.
A buyer amortizes acquired goodwill and other section 197 intangibles ratably over 15 years starting with the month of acquisition, and the covenant is amortized the same way — so where the price sits drives the buyer's deductions over time, and it is one reason the split is negotiated.
If buyer and seller agree in writing on the allocation, that agreement binds both unless the IRS determines it is not appropriate.
Model the split with your own tax adviser before the letter of intent.
Then the money not paid at closing.
An earn-out ties part of your price to targets hit after you have handed over the wheel — and the buyer runs the business those targets depend on, so negotiate how targets are defined and measured, and what happens if the platform itself is sold mid-earn-out.
Rollover equity pays part of the price as equity in the buyer's entity instead of cash; its value depends on a future transaction you are unlikely to control.
This research did not verify rollover-equity tax mechanics — whether contributing your equity is tax-deferred, for example — so treat any equity component as a question for your tax adviser.
The last string is attached to you: a transition period working for the buyer and a covenant not to compete.
Neither has a trustworthy "typical" — the only sources publishing standard transition or work-back periods, earn-out lengths or rollover percentages are broker marketing — so treat any such figure as an opening bid.
The covenant gets its own section below.
What non-compete and work-back terms will you sign?
When you sell, the non-compete flips sides: as a seller you are the one restricted, and the covenant is part of what the buyer is paying for.
In an asset sale it is a line item: a covenant not to compete entered into in connection with the acquisition is a section 197 intangible the buyer amortizes over 15 years.
How much of your future the covenant can wall off is state law, and sale covenants sit in a different category from employee ones.
California shows the pattern: state law there voids most employee non-competes, yet a person who sells a business's goodwill — or all of their ownership interest — may still agree with the buyer not to carry on a similar business within the specified geographic area where the business operated (California Business and Professions Code §16601).
The exception covers the goodwill or the whole ownership interest, so a partial sale can raise a different question — the line your own state draws is the one that matters.
Have a veterinary-specific attorney review scope, geography and length before you sign.
The employee-side covenants your associates sign are covered state by state in our veterinarian non-compete guide.
Do not count on federal law to shrink it.
As of October 7, 2026, the FTC's 2024 Non-Compete Clause Rule is not in effect and not enforceable, and in a final rule effective February 12, 2026 the FTC removed the Non-Compete Rule (16 CFR part 910) from the Code of Federal Regulations.
Enforceability of the covenant you sign is decided under state law, and which state's law applies is itself a contract term worth checking.
Negotiate the work-back and the covenant as a package with the earn-out, because together they define your next several years: where you can practice, whether relief work or consulting is off-limits, how much clinical time the buyer can require, and what happens to the unvested part of your price if you leave early.
Write down what you can live with before negotiations start.
What happens to your team when you sell?
Federal law splits WARN notice duties across a covered sale.
In a sale of a business covered by the WARN Act, the seller is responsible for any required notice up to and including the sale date and the buyer after it; for those notice duties, the seller's employees are treated as the buyer's employees immediately after the sale.
Whether those duties reach you is a headcount question: WARN coverage starts at employers with 100 or more employees (excluding part-time employees), or 100 or more employees working at least 4,000 hours a week in aggregate.
A practice under that line is not covered by those federal duties — confirm your headcount with employment counsel before assuming nothing applies.
Paperwork continuity has a specific rule: a buyer who keeps the seller's staff may treat them as continuing employees for Form I-9 purposes, without new I-9s, if it obtains and keeps the previous employer's I-9 records (8 CFR 274a.2).
Expect a buyer relying on those forms to review them closely, so a clean I-9 file is part of what you are selling — our Form I-9 guide for veterinary practices covers getting the file right.
What this research cannot hand you is a data-backed answer on benefits: it found no primary source on how staff benefits typically change after a corporate acquisition, so treat any ready promise as a negotiating position.
Make compensation, benefits and PTO accrual a written due-diligence question, and wait to announce until you can answer it — the corporate-versus-private question comes first, and our corporate vs private for staff guide gives your team an honest version to read.
Retention is deal value.
When the FTC required Mars to divest clinics in the VCA acquisition, the order required financial incentives for key employees at the divested clinics to stay, and barred Mars for a year from contracting with specialists affiliated with a divested clinic.
Regulators treated key-staff continuity as central enough to write into the order — ask any suitor, in writing, what they plan to do with your team.
How do you run the sale process?
A sale runs better as a sequence than as a negotiation you improvise.
From the seller's chair, the shape:
- Set your objectives in writing. Price, continuity for clients and staff, your own role after closing, and your hard limits on the covenant and work-back. These decide which buyer wins, not just which offer is highest.
- Build the data room. Several years of financials and tax returns, payroll, fee schedules, the equipment list, the lease, and an inventory of every license and registration the practice holds.
- Get a valuation you can defend — a supportable number from someone who values practices for a living, with the reasoning behind it, not a conference-hallway rule of thumb.
- Create competition. Talk to more than one buyer type in parallel, even if you end up preferring one. A broker can run this for you; if you interview brokers, have each describe in writing how they will market the practice, qualify buyers and protect confidentiality.
- Agree on structure in the letter of intent. Price, what is included (the real estate or not), the intended tax allocation, earn-out definitions, the transition schedule and the outline of your covenant — before exclusivity, not after.
- Get through due diligence. Expect the buyer to dig into the financials, payroll, licenses, controlled-substance handling, I-9 records and leases; your job is to verify the buyer's money and every clause that binds you personally. This research found no standard due-diligence checklist for practice purchases from a primary source, so build the list with your attorney and accountant rather than off a template.
- Close, then transition. The regulatory handoffs execute — the buyer's DEA registration path, the new premises registration where your state requires one — and, in an asset purchase where goodwill could attach, you and the buyer each generally file IRS Form 8594. Your work-back begins on the terms you negotiated.
Keep the team whole while the process runs, and say the word "selling" to your team only when you can answer their first question, which will be about them.
Before you take the first buyer meeting
- Write down what the sale is for: price, continuity, and the role you want after closing.
- Assemble several years of financial statements and tax returns, plus payroll, fee schedules and an equipment list.
- Map the entity structure, including whether the land and buildings are inside or outside the sale.
- Inventory every license and registration — a DEA registration does not transfer without DEA's written consent, and a California premises registration cannot be transferred at all.
- Clean up the Form I-9 file; a buyer who keeps your staff will rely on those records.
- Set your bottom line on the non-compete, the work-back schedule and any equity you are offered.
- Open conversations with more than one buyer type before you sign anything with one.